Bridgeway Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bridgeway Capital Management’s Portfolio CLDX Stock Details CLDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell
2020 Q1	$83K	Sell
2019 Q4	$172K	Sell
2019 Q3	$314K	Sell
2019 Q2	$549K	Buy
2019 Q1	$609K	Buy